✦ LIBER ✦

Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer

✍ Scribed by George Wilding; Gerald Grindey; Nikhil Munshi; David Seitz; Lawrence Einhorn

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 195 KB
Volume: 11
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00874156

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 3 randomized controlled trial of

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro

Randomized phase II study of atrasentan

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer

✍ M. Dror Michaelson; Donald S. Kaufman; Philip Kantoff; William K. Oh; Matthew R. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## BACKGROUND. Metastatic prostate cancer is characterized by the presence of osteoblastic bone metastases. Bone metastases account for most of the morbidity from this disease. Inhibition of osteoclast activity with the potent bisphosphonate zoledronic acid reduces skeletal complicatio

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi

Diethylstilbestrol and docetaxel : A pha

Diethylstilbestrol and docetaxel : A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

✍ R. Bruce Montgomery; Peter S. Nelson; Daniel Lin; Christopher W. Ryan; Mark Garz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND. The addition of diethylstilbestrol to docetaxel modified tubulin composition and improved the response of prostate cancer to chemotherapy in preclinical models. An attempt was made to recapitulate the observations in a clinical trial. ## METHODS. Twenty‐nine patients w

A phase I study of the somatostatin anal

A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer

✍ William D. Figg; Alain Thibault; Michael R. Cooper; Robert Reid; Donna Headlee; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

A Phase II trial of green tea in the tre

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

✍ Aminah Jatoi; Neil Ellison; Patrick A. Burch; Jeff A. Sloan; Shaker R. Dakhil; P 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: Recent laboratory and epidemiologic studies have suggested that green tea has antitumor effects in patients with prostate carcinoma. this phase ii trial explored green tea's antineoplastic effects in patients with androgen independent prostate carcinoma. ## Methods: This study, whi